antisense technology

18,991 views

Published on

presentation................

Published in: Education
3 Comments
15 Likes
Statistics
Notes
No Downloads
Views
Total views
18,991
On SlideShare
0
From Embeds
0
Number of Embeds
12
Actions
Shares
0
Downloads
1,051
Comments
3
Likes
15
Embeds 0
No embeds

No notes for slide

antisense technology

  1. 1. ANTISENSE TECHNOLOGY Presented By Desh Bandhu Gangwar M.Tech Biotech (2 year) Concerned Faculty Dr. Gunjan Garg Assistant Professor School of Biotechnology
  2. 2. INTRODUCTIONWhat is AntisenseTechnology ?
  3. 3. In this technique Short segments of single stranded DNA called oligo de oxy nucleotides are introduced.These oligonucleotides are complementary to the mRNA, which physically bind to the mRNA.
  4. 4. Antisense technology prevent the synthesis of specific protein.Antisense technologies are a suite of techniques that, together form a very powerful weapon for studying gene function and for discovering more specific treatments of disease.
  5. 5. Antisense OligonucleotidesWhat are AntisenseOligonucleotides?
  6. 6. The antisense effect of a oligonucleotide sequence was first demonstrated in 1970s by Zamecnik and Stephenson, in Rous sarcoma virus.AS-ONs usually consist of 15– 20 nucleotides, which are complementary to their target mRNA.
  7. 7. When these AS-ON combinedwith target mRNA, a DNA/RNAhybrid form,which degraded bythe enzyme RNase H. RNase H
  8. 8. RNase H is a non-specificendonuclease, catalyzes thecleavage of RNA via hydrolyticmechanism.RNase H has ribonucleaseactivity cleaves the 3’-O-P bondof RNA in a DNA/RNA duplex.
  9. 9. Mechanism of antisense activity
  10. 10. Types Of AS-ONFirst generation AS-ONSecond generation AS-ONThird generation AS-ON
  11. 11. A successful AS-ON depends on the followingcharacteristics: Unique DNA sequence Efficient cellular uptake Minimal nonspecific binding Target specific hybridization Non-toxic antisense construct Nuclease resistant to protect AS-ON
  12. 12. First generation AS-ONFirstsynthesized by Eckstein and colleagues.Phosphorothioate - oligo deoxy nucleotides are the major representatives of first generation DNA analogs that are the best known.
  13. 13. Sites of chemical modification
  14. 14. Phosphorothioate linkages in Ons primarily used to enhance their nuclease resistance.Inthis class of ONs, non bridging oxygen atoms in phopho-diester bond is replaced by sulfur.They first used as AS-ONs for the inhibition of HIV.
  15. 15. Characterstics of first generation AS-ONBetter stability to nucleases but still degrades.Decreased affinity to target mRNA.Enhanced specificity of hybridization.Toxic in nature.Can activate R Nase H.
  16. 16. Second generation AS-ONSecond generation ONs containing nucleotides with alkyl modifications at the 2’ position of the ribose. 2’-O-methyl and 2’-O-methoxy- ethyl RNA are the most important member of this class.
  17. 17. Characterstics of second generation AS-ONBest stability to nucleases.Increased affinity to target mRNA.Less toxic than first generation AS-ON.Can not activate R Nase.
  18. 18. Third generation AS-ONNewest and most promising.Enhance binding affinity and biostability.Peptide nucleic acids (PNAs)Locked nucleic acid (LNA)Tricyclo-DNA (tcDNA)Cyclohexene nucleic acids (CeNA)
  19. 19. Peptide nucleic acids In PNAs the deoxyribose phosphate backbone is replaced by polyamide linkages, which is composed of repeating N-(2-aminoethyl)-glycine units, linked by peptide bonds PNA was first introduced by Nielsen and coworkers in 1991. They are electrostatically neutral molecules
  20. 20. Locked nucleic acid LNA was synthesized by Jesper Wengel in 1998. The ribose moiety of LNA nucleotide is modified with an extra bridge connecting the 2 oxygen and 4 carbon
  21. 21. RibozymesThomas and coworkers coined the term ‘ribozymes.Ribozymes are RNA molecules that have catalytic activity.Ribozyme Bind to the target RNA moiety and inactivate it by cleaving the phosphodiester backbone at a specific cutting site.
  22. 22. Mechanism of Ribozymes
  23. 23. Types Of RibozymesTetrahymena group I intron RNase PHammer head ribozymeHairpin ribozymeHepatitis delta virus ribozyme
  24. 24. Cycle of RNA cleavage by hammerhead ribozyme
  25. 25. Ribozymes in clinical trialsANGIOZYME - VEGF-receptor1HERZYME - HER-2HEPTAZYM
  26. 26. RNA interference RNA interference (RNAi) is a system within living cells that takes part in controlling genes activity. Twotypes of small RNA molecules – (miRNA) and (siRNA) are central to RNA interference. Melloand Fire named the process RNAi, were awarded the Nobel Prize.
  27. 27. Mechanism of RNA interference
  28. 28. Comparision Of different Antisense stratgies
  29. 29. Applications Of Antisense technologies Story of Flavr Savr…
  30. 30. Antisense therapyß-thalassemiaCytomegalovirus retinitisHemorrhagic fever virusesDuchenne muscular dystrophyCancerHIV/AIDSHigh cholesterol
  31. 31. Antisense Drug Therapy
  32. 32. REFERENCE Gene cloning and DNA analysis, Fifth edition By T.A Brown Page no. 235 Walton, S. P., Roth, C. M., Yarmush, M. L. “Antisense Technology.”The Biomedical Engineering Handbook: Second Edition. Indian journal of chemistry vol. 48 B December 2009, pp. 1721-1726 Indian journal of biotechnology vol 4,JUL 2005,pp. 316 -322 Eur. J. Biochem. 270,1628–1644 Clinical and Experimental Pharmacology and Physiology (2006) 33, 533–540
  33. 33. QUERIES?
  34. 34. THANK YOU

×